Skip to main content
Sean McBride, MD, Radiation Oncology, New York, NY, Memorial Sloan-Kettering Cancer Center

SeanMatthewMcBrideMDMPH

Radiation Oncology New York, NY

Head & Neck, Urologic Cancer

Assistant Attending, Memorial Sloan Kettering Cancer Center

Overview of Dr. McBride

Dr. Sean McBride is a radiation oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from Yale School of Medicine and has been in practice 9 years. He is one of 91 doctors at Memorial Sloan-Kettering Cancer Center who specialize in Radiation Oncology. He has more than 40 publications and over 100 citings.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2009 - 2013
  • California Pacific Medical Center
    California Pacific Medical CenterInternship, Internal Medicine, 2008 - 2009
  • Yale School of Medicine
    Yale School of MedicineClass of 2008

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2015 - 2019
  • NY State Medical License
    NY State Medical License 2013 - 2024
  • MA State Medical License
    MA State Medical License 2011 - 2014
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Lectures

  • Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Apalutamide + abiraterone + leuprolide with stereotactic, ultra-hypofractionated radiation (AASUR) in very high risk prostate cancer (PCa). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Join now to see all

Press Mentions

  • New SU2C Teams Accelerate Clinical Trials for Difficult Breast & Prostate Cancers
    New SU2C Teams Accelerate Clinical Trials for Difficult Breast & Prostate CancersSeptember 16th, 2019
  • New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck Cancer
    New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck CancerJanuary 25th, 2022
  • ‘Contrary’ to Wide Belief, Abscopal Effect Is Rare in Cancer
    ‘Contrary’ to Wide Belief, Abscopal Effect Is Rare in CancerJanuary 14th, 2021

Hospital Affiliations